Order Article Reprints

Cojutti PG, Carnelutti A, Lazzarotto D, Sozio E, Candoni A, Fanin R, Tascini C, Pea F. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles? Pharmaceutics. 2021; 13(12):2099. https://doi.org/10.3390/pharmaceutics13122099

Cojutti, Pier Giorgio, Alessia Carnelutti, Davide Lazzarotto, Emanuela Sozio, Anna Candoni, Renato Fanin, Carlo Tascini, and Federico Pea. 2021. "Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles?" Pharmaceutics 13, no. 12: 2099. https://doi.org/10.3390/pharmaceutics13122099

Cojutti, P. G., Carnelutti, A., Lazzarotto, D., Sozio, E., Candoni, A., Fanin, R., Tascini, C., & Pea, F. (2021). Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles? Pharmaceutics, 13(12), 2099. https://doi.org/10.3390/pharmaceutics13122099